Showing results (1231-1240 of 2,904) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|July 30, 2005
Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer modelT Saika, N Kusaka, V Mouraviev, et al.Cancer Gene Therapy|May 20, 2006
Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNAJ A Kyte, L Mu, S Aamdal, et al.Cancer Gene Therapy|May 29, 2010
Targeting HSV-1 virions for specific binding to epidermal growth factor receptor-vIII-bearing tumor cellsP Grandi, J Fernandez, O Szentirmai, et al.Cancer Gene Therapy|October 2, 2010
Carrier cell-based delivery of replication-competent HSV-1 mutants enhances antitumor effect for ovarian cancerS Fujiwara, A Nawa, C Luo, et al.Cancer Gene Therapy|October 2, 2010
Effects of siRNA-targeting BMP-2 on the abilities of migration and invasion of human liver cancer SMMC7721 cells and its mechanismJ-B Wu, H-Q Fu, L-Z Huang, et al.Cancer Gene Therapy|October 2, 2010
Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancersJ T-C Chang, T-F Kuo, Y-J Chen, et al.Cancer Gene Therapy|October 2, 2010
Lentiviral transfer of an inducible transgene expressing a soluble form of Gas1 causes glioma cell arrest, apoptosis and inhibits tumor growthA López-Ornelas, T Mejía-Castillo, P Vergara, et al.Cancer Gene Therapy|July 3, 2010
A fully replication-competent adenovirus vector with enhanced oncolytic propertiesK Toth, M Kuppuswamy, E V Shashkova, et al.Cancer Gene Therapy|August 14, 2010
Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patientsE Luzi, F Marini, I Tognarini, et al.Cancer Gene Therapy|August 7, 2010
A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinomaB Sangro, G Mazzolini, M Ruiz, et al.Pageof 291